Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120


Molecular characterization of human T-cell lymphotropic virus type 1 full and partial genomes by Illumina massively parallel sequencing technology.

Pessôa R, Watanabe JT, Nukui Y, Pereira J, Casseb J, de Oliveira AC, Segurado AC, Sanabani SS.

PLoS One. 2014 Mar 31;9(3):e93374. doi: 10.1371/journal.pone.0093374. eCollection 2014. Erratum in: PLoS One. 2014;9(7):e102223. Kasseb, Jorge [corrected to Casseb, Jorge].


Phylogenetic classification of human T cell leukaemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes.

Vidal AU, Gessain A, Yoshida M, Tekaia F, Garin B, Guillemain B, Schulz T, Farid R, De Thé G.

J Gen Virol. 1994 Dec;75 ( Pt 12):3655-66.


Deep Sequencing Analysis of Human T Cell Lymphotropic Virus Type 1 Long Terminal Repeat 5' Region from Patients with Tropical Spastic Paraparesis/Human T Cell Lymphotropic Virus Type 1-Associated Myelopathy and Asymptomatic Carriers.

Rego FF, de Oliveira T, Giovanetti M, Galvão-Castro B, Gonçalves Mde S, Alcantara LC.

AIDS Res Hum Retroviruses. 2016 Mar;32(3):279-83. doi: 10.1089/AID.2015.0273. Epub 2015 Nov 10.


Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals.

Mota-Miranda AC, Barreto FK, Amarante MF, Batista E, Monteiro-Cunha JP, Farre L, Galvão-Castro B, Alcantara LC.

Virol J. 2013 Mar 6;10:75. doi: 10.1186/1743-422X-10-75.


Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.

Nozuma S, Matsuura E, Kodama D, Tashiro Y, Matsuzaki T, Kubota R, Izumo S, Takashima H.

Retrovirology. 2017 Apr 19;14(1):26. doi: 10.1186/s12977-017-0350-9.


Genetic characterization of human T-cell lymphotropic virus type 1 in Mozambique: transcontinental lineages drive the HTLV-1 endemic.

Vicente AC, Gudo ES, Iñiguez AM, Otsuki K, Bhatt N, Abreu CM, Vubil A, Bila D, Ferreira OC, Tanuri A, Jani IV; HTLV in Mozambique Study Group.

PLoS Negl Trop Dis. 2011 Apr 12;5(4):e1038. doi: 10.1371/journal.pntd.0001038.


Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.

Grassi MF, Olavarria VN, Kruschewsky Rde A, Mascarenhas RE, Dourado I, Correia LC, de Castro-Costa CM, Galvão-Castro B.

J Med Virol. 2011 Jul;83(7):1269-74. doi: 10.1002/jmv.22087.


Genetic characterization and phylogeny of human T-cell lymphotropic virus type I from Chile.

Ramirez E, Cartier L, Villota C, Fernandez J.

Virus Res. 2002 Mar 20;84(1-2):135-49.


Genetic and phylogenetic analyses of human T-cell lymphotropic virus type I variants from Melanesians with and without spastic myelopathy.

Nerurkar VR, Song KJ, Melland RR, Yanagihara R.

Mol Neurobiol. 1994 Apr-Jun;8(2-3):155-73.


Tax secretion from peripheral blood mononuclear cells and Tax detection in plasma of patients with human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis and asymptomatic carriers.

Medina F, Quintremil S, Alberti C, Godoy F, Pando ME, Bustamante A, Barriga A, Cartier L, Puente J, Tanaka Y, Valenzuela MA, Ramírez E.

J Med Virol. 2016 Mar;88(3):521-31. doi: 10.1002/jmv.24342. Epub 2015 Oct 19.


Genetic markers on the HTLV-1 p12I protein sequences from Brazilian HAM/TSP patients and asymptomatic HTLV-1 carrier isolates.

Iñiguez AM, Otsuki K, Magalhães GP, Silva EA, Vicente AC.

AIDS Res Hum Retroviruses. 2005 Jun;21(6):580-2.


Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.

Furtado Mdos S, Andrade RG, Romanelli LC, Ribeiro MA, Ribas JG, Torres EB, Barbosa-Stancioli EF, Proietti AB, Martins ML.

J Med Virol. 2012 Apr;84(4):664-71. doi: 10.1002/jmv.23227.


Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau.

van Tienen C, de Silva TI, Alcantara LC, Onyango CO, Jarju S, Gonçalves N, Vincent T, Aaby P, Whittle H, Schim van der Loeff M, Cotten M.

PLoS Negl Trop Dis. 2012;6(6):e1690. doi: 10.1371/journal.pntd.0001690. Epub 2012 Jun 12.


Nucleotide sequence analysis of human T-cell lymphotropic virus type I pX and LTR regions from patients with sicca syndrome.

Beby-Defaux A, Frugier F, Bourgoin A, Moynet D, Hajjar C, Sainte-Foie S, Guillemain B, Agius G.

J Med Virol. 1999 Oct;59(2):245-55.


Short communication an interferon-γ ELISPOT assay with two cytotoxic T cell epitopes derived from HTLV-1 tax region 161-233 discriminates HTLV-1-associated myelopathy/tropical spastic paraparesis patients from asymptomatic HTLV-1 carriers in a Peruvian population.

Best I, López G, Talledo M, MacNamara A, Verdonck K, González E, Tipismana M, Asquith B, Gotuzzo E, Vanham G, Clark D.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1207-12. doi: 10.1089/AID.2011.0029. Epub 2011 May 9.


Quantification of HTLV type I and HIV type I DNA load in coinfected patients: HIV type 1 infection does not alter HTLV type I proviral amount in the peripheral blood compartment.

Césaire R, Dehée A, Lézin A, Désiré N, Bourdonné O, Dantin F, Béra O, Smadja D, Abel S, Cabié A, Sobesky G, Nicolas JC.

AIDS Res Hum Retroviruses. 2001 Jun 10;17(9):799-805.


Human T-cell lymphotropic virus type I (HTLV-I) proviral DNA viral load among asymptomatic patients and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.

Montanheiro PA, Oliveira AC, Posada-Vergara MP, Milagres AC, Tauil C, Marchiori PE, Duarte AJ, Casseb J.

Braz J Med Biol Res. 2005 Nov;38(11):1643-7. Epub 2005 Oct 26. Erratum in: Braz J Med Biol Res. 2005 Dec;38(12):1890. Montanheito, PA [corrected to Montanheiro, PA].


Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.

Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN, Bangham CR.

J Immunol. 2004 Feb 1;172(3):1735-43.

Supplemental Content

Support Center